XML 68 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation
12 Months Ended
Jun. 30, 2012
Share-Based Compensation [Abstract]  
Share-Based Compensation

11. Share-Based Compensation

     We have Stock Incentive Plans providing for the grant of incentive stock options to employees and non-qualified stock options to employees and directors. The Compensation Committee of the Board of Directors ("Compensation Committee") administers the Stock Option Plans. Under the plans, the Compensation Committee may award stock options and shares of Common Stock on a restricted basis. The plans also specifically provide for stock appreciation rights and authorize the Compensation Committee to provide, either at the time of the grant of an option or otherwise, that the option may be cashed out upon terms and conditions to be determined by the Committee or the Board.

     Option awards are granted with an exercise price equal to the market price of our stock at the date of grant. We recognize stock compensation expense in accordance with ASC 718-10 over the requisite service period of the individual grantees, which generally equals the vesting period. All of our stock compensation is accounted for as equity instruments.

     Our 2011 Stock Incentive Plan became effective November 1, 2011 and replaced the 2001 Stock Option Plan that expired on October 31, 2011. As of November 1, 2011 there were no shares of Common Stock available for future grant under the 2001 Stock Option Plan. The 2011 Stock Incentive Plan terminates on October 31, 2021. Stockholders have authorized the issuance of up to 500,000 shares under this plan, and at June 30, 2012, there were 445,000 shares available for future grants.

     We recorded share-based compensation related to issuance of stock options and restricted stock to employees, board members, and non-employees, as follows (amounts in thousands of dollars):

    Year Ended June 30,
    2012   2011   2010
Share-based compensation expense included in the            
Statement of Operations:            
Cost of sales $ 55 $ 50 $ 23
Sales and marketing   133   286   97
Research and development   102   171   92
General and administrative   426   719   458
Total   716   1,226   670
Tax benefit   -   -   -
Share-based compensation expense, net of taxes $ 716 $ 1,226 $ 670

 

     We use the Black-Scholes valuation model to estimate the fair value of each option award on: 1) the date of grant for grants to employees, and 2) each reporting period-end date for grants to non-employees, until the non-employee shares have vested, at which point the vest date becomes the final measurement date for non-employee grants. We did not grant any stock options in fiscal years 2012, 2011 and 2010, and there were no unvested options granted to non-employees as of June 30, 2012.

     Based on historical experience of restricted stock and option pre-vesting cancellations, we estimated an annualized forfeiture rate of 9.00% for unvested restricted stock awards and stock options outstanding as of June 30, 2012. We estimated a 5.75% forfeiture rate for restricted stock awards and stock options outstanding as of June 30, 2011. We update our expectation of forfeiture rates quarterly and under the true-up provisions of ASC 718-10, we will record additional expense if the actual forfeiture rate is lower than estimated, and will record a recovery of prior expense if the actual forfeiture is higher than estimated.

     A summary of option activity under the plans as of June 30, 2012, and changes during the year is presented below:

          Weighted-    
        Weighted- Average    
        Average Remaining   Aggregate
        Exercise Contractual   Intrinsic
Options Shares     Price Term (Years)   Value
 
Outstanding as of July 1, 2011 309,425   $ 25.22      
Granted -   $ -      
Exercised -   $ -      
Forfeited or expired (53,659 ) $ 75.61      
Outstanding as of June 30, 2012 255,766   $ 14.65 4.45 $ -
Vested or expected to vest at June 30,              
2012 255,766   $ 14.65 4.45 $ -
Exercisable at June 30, 2012 250,766   $ 14.81 4.42 $ -

 

     The following table summarizes information about stock options outstanding and exercisable at June 30, 2012:

    Outstanding Options Options Exercisable
    Weighted            
    Average     Weighted     Weighted
  Range of Remaining     Average     Average
  Exercise Contractual June 30,   Exercise June 30,   Exercise
  Prices Life (Years) 2012   Price 2012   Price
 
$ 6.40- $ 6.40 6.09 20,000 $ 6.40 15,000 $ 6.40
$ 7.30- $ 7.30 5.81 60,000 $ 7.30 60,000 $ 7.30
$ 11.60- $13.50 4.39 48,829 $ 13.31 48,829 $ 13.31
$ 14.00- $14.00 4.99 56,843 $ 14.00 56,843 $ 14.00
$ 15.20- $49.40 2.42 70,094 $ 24.75 70,094 $ 24.75
$ 6.40- $49.40 4.45 255,766 $ 14.65 250,766 $ 14.81

 

     The total intrinsic value of options both outstanding and exercisable was $0 for each of the fiscal years ended June 30, 2012, 2011 and 2010, respectively. Total compensation cost of options granted but not yet vested as of June 30, 2012 is $2,000, which is expected to be recognized over the weighted average period of one month. We generally issue new shares to satisfy option exercises.

     We have not received any cash from option exercises under all share-based payment arrangements for the fiscal years ended June 30, 2012, 2011 and 2010.

     During fiscal year 2012, we issued 94,000 shares of restricted stock to employees and board members that vest over either a three or four year service period. Vesting is based solely on a service condition, and restrictions generally release ratably over the service period. A summary of the activity of our service condition restricted shares during our fiscal year 2012 is presented below:

        Weighted-
        Average
        Grant-Date
Restricted Stock Awards Shares     Fair-Value
Non-vested at July 1, 2011 330,644   $ 5.05
Granted 94,000     4.79
Vested (118,129 )   4.92
Forfeited (60,449 )   5.37
Non-vested at June 30, 2012 246,066   $ 4.94

 

     During fiscal years 2009, 2010 and 2011, we issued performance-based restricted shares to senior and executive management and board members that will be released only if either company performance criteria or market condition criteria are achieved over a three year performance period. The performance criteria are determined each year and require us to achieve certain annual revenue and operating income goals. To the extent that these annual goals are met, a portion of the shares will vest and be released. The market condition requires our stock to reach a certain closing share price at the end of three years. Provided that the market condition is met, any remaining shares that did not vest based on the performance condition will become fully vested at the end of the three years. During fiscal year 2012 we released restrictions on 101,017 performance-based restricted shares, respectively, for certain shares granted to executive management and the board of directors that were eligible for release due to our achievement of performance criteria related to our fiscal 2011 financial results. We cancelled 132,184 performance-based restricted shares during fiscal year 2012 for restricted shares granted to executive management and board members that were either forfeited or expired during the period primarily because neither the performance criteria for our fiscal 2009, 2010 and 2011 financial results, nor the market condition (achievement of certain share price) were met. The weighted average grant-date fair-value for our performance shares was based upon a Geometric Brownian Motion model and Monte Carlo simulation. A summary of the activity of our performance based restricted shares during fiscal year 2012, is presented below:

        Weighted-
        Average
        Grant-Date
Performance Stock Awards Shares     Fair-Value
Non-vested at July 1, 2011 452,055   $ 2.09
Granted -     -
Vested (101,017 )   1.96
Forfeited (132,184 )   2.11
Non-vested at June 30, 2012 218,854   $ 2.25

 

     Total compensation cost of restricted stock awards issued, but not yet vested as of June 30, 2012 is $1,010,000, which is expected to be recognized over the weighted average period of 1.42 years.